Abstract
Rationale
Sigma-1 receptor agonists are under investigation as potential disease-modifying agents for several CNS disorders. Donepezil, an acetylcholinesterase inhibitor used for the symptomatic treatment of Alzheimer’s disease, is also a high-affinity sigma-1 agonist.
Objectives
The objectives of the present study were to investigate if the sigma-1 agonist tracer 11C-SA4503 and microPET can be used to determine sigma-1 receptor occupancy (RO) of donepezil in the rat brain; to establish RO of donepezil at doses commonly used in rodent behavioural studies; and to determine the effective plasma concentration of donepezil required for 50 % of max-min occupancy (EC50).
Methods
Male Wistar rats were pre-treated with donepezil (0.1 to 10 mg/kg) for about 1 h before microPET scans using 11C-SA4503. The total distribution volume (V T) of the tracer was determined by Logan graphical analysis using time activity curves from arterial plasma and regions of interest drawn around the entire brain and individual brain regions. RO by donepezil was calculated from a modified Lassen plot, and ED50 was estimated from the sigmoidal dose-response curves obtained when the RO was plotted against log donepezil dose.
Results
A dose-dependent reduction was observed for V T in the whole brain as well as individual brain regions. RO increased dose-dependently and was 93 % at 10 mg/kg. ED50 was 1.29 mg/kg.
Conclusions
Donepezil, in the common dose range, was found to dose-dependently occupy a significant fraction of the sigma-1 receptor population. The data indicate that it is possible to determine sigma-1 RO by an agonist drug in rat brain, using 11C-SA4503 and microPET.
Similar content being viewed by others
References
Abadias M, Escriche M, Vaque A, Sust M, Encina G (2013) Safety, tolerability and pharmacokinetics of single and multiple doses of a novel sigma-1 receptor antagonist in three randomized phase I studies. Br J Clin Pharmacol 75:103–117
Bohnen NI, Kaufer DI, Hendrickson R, Ivanco LS, Lopresti BJ, Koeppe RA, Meltzer CC, Constantine G, Davis JG, Mathis CA, Dekosky ST, Moore RY (2005) Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by donepezil treatment in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 76:315–319
Cunningham VJ, Rabiner EA, Slifstein M, Laruelle M, Gunn RN (2010) Measuring drug occupancy in the absence of a reference region: the Lassen plot re-visited. J Cereb Blood Flow Metab 30:46–50
de Greef R, Maloney A, Olsson-Gisleskog P, Schoemaker J, Panagides J (2011) Dopamine D2 occupancy as a biomarker for antipsychotics: quantifying the relationship with efficacy and extrapyramidal symptoms. AAPS J 13(1):121–130
Ferris RM, Tang FL, Chang KJ, Russell A (1986) Evidence that the potential antipsychotic agent rimcazole (BW 234U) is a specific, competitive antagonist of sigma sites in brain. Life Sci 38:2329–2337
Geerts H, Guillaumat PO, Grantham C, Bode W, Anciaux K, Sachak S (2005) Brain levels and acetylcholinesterase inhibition with galantamine and donepezil in rats, mice, and rabbits. Brain Res 1033:186–193
Goh CW, Aw CC, Lee JH, Chen CP, Browne ER (2011) Pharmacokinetic and pharmacodynamic properties of cholinesterase inhibitors donepezil, tacrine, and galantamine in aged and young Lister hooded rats. Drug Metab Dispos 39:402–411
Heydorn WE (1997) Donepezil (E2020): a new acetylcholinesterase inhibitor. Review of its pharmacology, pharmacokinetics, and utility in the treatment of Alzheimer’s disease. Expert Opin Investig Drugs 6:1527–1535
Hirano K, Piers TM, Searle KL, Miller ND, Rutter AR, Chapman PF (2009) Procognitive 5-HT6 antagonists in the rat forced swimming test: potential therapeutic utility in mood disorders associated with Alzheimer’s disease. Life Sci 84:558–562
Ishikawa M, Sakata M, Ishii K, Kimura Y, Oda K, Toyohara J, Wu J, Ishiwata K, Iyo M, Hashimoto K (2009) High occupancy of sigma1 receptors in the human brain after single oral administration of donepezil: a positron emission tomography study using [11C]SA4503. Int J Neuropsychopharmacol 12:1127–1131
Julien-Dolbec C, Tropres I, Montigon O, Reutenauer H, Ziegler A, Decorps M, Payen JF (2002) Regional response of cerebral blood volume to graded hypoxic hypoxia in rat brain. Br J Anaesth 89:287–293
Kaasinen V, Någren K, Järvenpää T, Roivainen A, Yu M, Oikonen V, Kurki T, Rinne JO (2002) Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer’s disease. J Clin Psychopharmacol 22:615–620
Kato K, Hayako H, Ishihara Y, Marui S, Iwane M, Miyamoto M (1999) TAK-147, an acetylcholinesterase inhibitor, increases choline acetyltransferase activity in cultured rat septal cholinergic neurons. Neurosci Lett 260:5–8
Kawamura K, Elsinga PH, Kobayashi T, Ishii S, Wang WF, Matsuno K, Vaalburg W, Ishiwata K (2003) Synthesis and evaluation of 11C- and 18F-labeled 1-[2-(4-alkoxy-3-methoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazines as sigma receptor ligands for positron emission tomography studies. Nucl Med Biol 30:273–284
Kosasa T, Kuriya Y, Matsui K, Yamanishi Y (1999) Inhibitory effects of donepezil hydrochloride (E2020) on cholinesterase activity in brain and peripheral tissues of young and aged rats. Eur J Pharmacol 386:7–13
Kuhl DE, Minoshima S, Frey KA, Foster NL, Kilbourn MR, Koeppe RA (2000) Limited donepezil inhibition of acetylcholinesterase measured with positron emission tomography in living Alzheimer cerebral cortex. Ann Neurol 48:391–395
Kunitachi S, Fujita Y, Ishima T, Kohno M, Horio M, Tanibuchi Y, Shirayama Y, Iyo M, Hashimoto K (2009) Phencyclidine-induced cognitive deficits in mice are ameliorated by subsequent subchronic administration of donepezil: role of sigma-1 receptors. Brain Res 1279:189–196
Lassen NA, Bartenstein PA, Lammertsma AA, Prevett MC, Turton DR, Luthra SK, Osman S, Bloomfield PM, Jones T, Patsalos PN (1995) Benzodiazepine receptor quantification in vivo in humans using [11C]flumazenil and PET: application of the steady-state principle. J Cereb Blood Flow Metab 15:152–165
Lindner MD, Hogan JB, Hodges DB Jr, Orie AF, Chen P, Corsa JA, Leet JE, Gillman KW, Rose GM, Jones KM, Gribkoff VK (2006) Donepezil primarily attenuates scopolamine-induced deficits in psychomotor function, with moderate effects on simple conditioning and attention, and small effects on working memory and spatial mapping. Psychopharmacology (Berl) 188:629–640
Matsuno K, Kobayashi T, Tanaka MK, Mita S (1996) Sigma 1 receptor subtype is involved in the relief of behavioral despair in the mouse forced swimming test. Eur J Pharmacol 312:267–271
Maurice T, Meunier J, Feng B, Ieni J, Monaghan DT (2006) Interaction with sigma(1) protein, but not N-methyl-d-aspartate receptor, is involved in the pharmacological activity of donepezil. J Pharmacol Exp Ther 317:606–614
Narita N, Hashimoto K, Tomitaka S, Minabe Y (1996) Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain. Eur J Pharmacol 307:117–119
Nirogi R, Bhyrapuneni G, Kandikere V, Benade V, Muddana N, Saralaya R, Irappanavar S, Ponnamaneni R, Mukkanti K (2012) Concurrent administration of atypical antipsychotics and donepezil: drug interaction study in rats. Eur J Drug Metab Pharmacokinet
Ramakrishnan NK, Rybczynska AA, Visser AK, Marosi K, Nyakas CJ, Kwizera C, Sijbesma JW, Elsinga PH, Ishiwata K, Pruim J, Dierckx RA, van Waarde A (2013) Small-animal PET with a sigma-ligand, 11C-SA4503, detects spontaneous pituitary tumors in aged rats. J Nucl Med 54:1377–1383
Ramakrishnan NK, Rybczynska AA, Visser AK, van Waarde A, Elsinga PH, Ishiwata K, Luiten PG, Dierckx RA (2011) Quantification of sigma-1 receptors in rat brain using 11C-SA4503 and microPET. XXVth International Symposium on Cerebral Blood Flow, Metabolism and Function, Barcelona, Spain. Abstract no. 256. http://kenes.com/brain2011/abstracts/pdf/256.pdf
Sakata M, Kimura Y, Naganawa M, Oda K, Ishii K, Chihara K, Ishiwata K (2007) Mapping of human cerebral sigma1 receptors using positron emission tomography and [11C]SA4503. Neuroimage 35:1–8
Schweinhardt P, Fransson P, Olson L, Spenger C, Andersson JL (2003) A template for spatial normalisation of MR images of the rat brain. J Neurosci Methods 129:105–113
Shinotoh H, Aotsuka A, Fukushi K, Nagatsuka S, Tanaka N, Ota T, Tanada S, Irie T (2001) Effect of donepezil on brain acetylcholinesterase activity in patients with AD measured by PET. Neurology 56:408–410
Sugimoto Y, Tagawa N, Kobayashi Y, Mitsui-Saito K, Hotta Y, Yamada J (2012) Involvement of the sigma1 receptor in the antidepressant-like effects of fluvoxamine in the forced swimming test in comparison with the effects elicited by paroxetine. Eur J Pharmacol 696:96–100
Tam SW, Cook L (1984) Sigma opiates and certain antipsychotic drugs mutually inhibit (+)-[3H] SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes. Proc Natl Acad Sci U S A 81:5618–5621
Urfer R, Takao K, Sato W, Yoshikawa K, Ishiwata K, Mita S (2009) SA4503 is a potent and selective sigma-1 receptor agonist in clinical development for depression and stroke recovery. Soc Neurosci Abstr 496:3
van Waarde A, Ramakrishnan NK, Rybczynska AA, Elsinga PH, Ishiwata K, Nijholt IM, Luiten PG, Dierckx RA (2011) The cholinergic system, sigma-1 receptors and cognition. Behav Brain Res 221:543–554
van Waarde A, Rybczynska AA, Ramakrishnan N, Ishiwata K, Elsinga PH, Dierckx RA (2010) Sigma receptors in oncology: therapeutic and diagnostic applications of sigma ligands. Curr Pharm Des 16:3519–3537
Villard V, Meunier J, Chevallier N, Maurice T (2011) Pharmacological interaction with the sigma1 (sigma1)-receptor in the acute behavioral effects of antidepressants. J Pharmacol Sci 115:279–292
Yuede CM, Dong H, Csernansky JG (2007) Anti-dementia drugs and hippocampal-dependent memory in rodents. Behav Pharmacol 18:347–363
Acknowledgments
We would like to thank Chantal Kwizera for the tracer synthesis and Jurgen WA Sijbesma, Mohammed Khayum, Siddesh Hartimath, Soumen Paul, Vladimir Shalgunov and Willem Jan Kuik for the assistance during the scanning procedure. This study was supported by University funding (bursary stipend to NKR).
Conflict of interest
There are no circumstances that could be perceived as a potential conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM S1
(PDF 22 kb)
Rights and permissions
About this article
Cite this article
Ramakrishnan, N.K., Visser, A.K.D., Schepers, M. et al. Dose-dependent sigma-1 receptor occupancy by donepezil in rat brain can be assessed with 11C-SA4503 and microPET. Psychopharmacology 231, 3997–4006 (2014). https://doi.org/10.1007/s00213-014-3533-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-014-3533-2